UBS analyst Ashwani Verma increased the price target for Teva Pharmaceutical Industries Ltd (NYSE:TEVA) to $30 from the previous $28 while keeping a Buy rating on the shares. Verma highlighted Teva as ...
Maynilad Water Services has hired banks including Morgan Stanley and UBS to work on a more than $500-million initial public offering (IPO) in the Philippines, according to two sources with knowledge ...
Retirement is often imagined as a carefree phase of life, filled with relaxation, hobbies, and quality time with loved ones. Rising interest in alternative investments — such as private equity, real ...
UBS analysts said that if the 10-year bond yield (US10Y) reaches 5% – currently at 4.65% and in an upward slope – equities would see a negative impact. Andrew Garthwaite, chief global equity ...
As news trickled out about President Trump's announcement of a new $500 billion Stargate joint venture focused on artificial-intelligence infrastructure, some potential beneficiaries emerged.
Iovance Biotherapeutics Inc (IOVA) stock saw a modest uptick, ending the day at $5.99 which represents a slight increase of $0.11 or 1.87% from the prior close of $5.88. The stock opened at $5.9 and ...
UBS has received a new waiver from the U.S. Department of Labor to manage U.S. retirement plans. This comes after the Swiss ...
Chief Executive Officer John McKenzie will present at the 2025 Bank of America Financial Services Conference on Monday, February 10, 2025, at 8:50 a.m. - 9:30 a.m. ET.Mr. McKenzie will also present at ...
What do we expect from Budget 2025? UBS says changes in tax policy unlikely, especially for capital markets, expect measures ...
BMO Capital analyst John McNulty maintained a Hold rating on Hexcel (HXL – Research Report) yesterday and set a price target of $72.00.Invest ...
The latest earnings results have been impressive so far, but UBS says they may have been impacted by President Trump's ...
Loss of breadth: Check. A handful of technology giants-what UBS calls the 'Magnificent Six,' which excludes Tesla -are driving the market, while smaller stocks lag. The average 12-month forward ...